{"transactions":[{"id":704630,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Performance Right","published_at":"2026-07-23T00:06:02.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":21288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":21288,"derivative":{"underlying":"Common Stock","underlying_shares":21288},"source":{"system":"sec-edgar","filing":"0001140361-26-029330","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029330/form4.xml","form_type":"4"}},{"id":704629,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-07-23T00:06:02.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":21288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 21,288 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 21,288 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 15, 2027, such that 25% of the restricted stock units will vest on each of July 15, 2027, 2028, 2029 and 2030."}],"balance_after":112618,"source":{"system":"sec-edgar","filing":"0001140361-26-029330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029330/form4.xml","form_type":"4"}},{"id":705131,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-07-22T00:36:47.000Z","date":"2026-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2267,"price":14.14,"value":32055.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 2,267 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025."}],"balance_after":91330,"source":{"system":"sec-edgar","filing":"0001140361-26-029190","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029190/form4.xml","form_type":"4"}},{"id":1014572,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-10-22T11:00:16.000Z","date":"2025-10-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":11.81,"value":118100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.71 to $11.90, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":93597,"source":{"system":"sec-edgar","filing":"0001140361-25-038873","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125038873/form4.xml","form_type":"4"}},{"id":1084583,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Performance Right","published_at":"2025-07-18T22:06:25.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":30900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":30900,"derivative":{"underlying":"Common Stock","underlying_shares":30900},"source":{"system":"sec-edgar","filing":"0001140361-25-026463","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026463/form4.xml","form_type":"4"}},{"id":1084582,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-07-18T22:06:25.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":30900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 30,900 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 30,900 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029."}],"balance_after":83597,"source":{"system":"sec-edgar","filing":"0001140361-25-026463","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026463/form4.xml","form_type":"4"}},{"id":1342692,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-12-05T02:33:45.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":103650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These stock options vest in four equal annual installments beginning on December 2, 2025, such that 25% of the options will vest on each of December 2, 2025, 2026, 2027 and 2028."}],"balance_after":103650,"derivative":{"exercise_price":7.14,"exercise_date":"2025-12-02","expiration_date":"2034-12-02","underlying":"Common Stock","underlying_shares":103650},"source":{"system":"sec-edgar","filing":"0001140361-24-048416","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124048416/form4.xml","form_type":"4"}},{"id":1342691,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"officer":true,"officer_title":"SVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-12-05T02:33:45.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":52697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 52,697 shares of common stock (\"Common Stock\") of AngioDynamics, Inc.(\"AngioDynamics\") represents 52,697 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on December 2, 2025, such that 25% of the restricted stock units will vest on each of December 2, 2025, 2026, 2027 and 2028."}],"balance_after":52697,"source":{"system":"sec-edgar","filing":"0001140361-24-048416","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124048416/form4.xml","form_type":"4"}},{"id":1833441,"issuer":{"id":4467,"kind":"organization","name":"Butterfly Network, Inc.","symbol":"BFLY"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO, GC and Corp Sec"}}],"security":"Class A Common Stock","published_at":"2023-07-06T21:44:28.000Z","date":"2023-07-05","kind":"sale","planned":true,"acquired":false,"shares":27655,"price":2.188,"value":60509.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and intended to qualify under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $2.15 to $2.315 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1236838,"source":{"system":"sec-edgar","filing":"0001104659-23-078836","document":"tm2320777-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804176/000110465923078836/tm2320777-1_4seq1.xml","form_type":"4"}},{"id":1875822,"issuer":{"id":4467,"kind":"organization","name":"Butterfly Network, Inc.","symbol":"BFLY"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO, GC and Corp Sec"}}],"security":"Class A Common Stock","published_at":"2023-05-26T20:17:14.000Z","date":"2023-05-24","kind":"sale","planned":false,"acquired":false,"shares":52296,"price":2.2196,"value":116076.2016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and intended to qualify under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $2.16 to $2.28 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1264493,"source":{"system":"sec-edgar","filing":"0001104659-23-065477","document":"tm2317164-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804176/000110465923065477/tm2317164-1_4seq1.xml","form_type":"4"}},{"id":1971129,"issuer":{"id":4467,"kind":"organization","name":"Butterfly Network, Inc.","symbol":"BFLY"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO, GC and Corp Sec"}}],"security":"Class A Common Stock","published_at":"2023-03-03T23:00:44.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":452000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33.33% on each anniversary of the grant date, subject to Mr. Weiss's continued service through the applicable vesting date."}],"balance_after":1316789,"source":{"system":"sec-edgar","filing":"0001562180-23-002439","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804176/000156218023002439/primarydocument.xml","form_type":"4"}},{"id":1971128,"issuer":{"id":4467,"kind":"organization","name":"Butterfly Network, Inc.","symbol":"BFLY"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO, GC and Corp Sec"}}],"security":"Class A Common Stock","published_at":"2023-03-03T23:00:44.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":174000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 50% on July 1, 2023 with the remainder vesting on January 1, 2024, subject to Mr. Weiss's continued service through the applicable vesting date."}],"balance_after":864789,"source":{"system":"sec-edgar","filing":"0001562180-23-002439","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804176/000156218023002439/primarydocument.xml","form_type":"4"}},{"id":2257641,"issuer":{"id":4467,"kind":"organization","name":"Butterfly Network, Inc.","symbol":"BFLY"},"owners":[{"id":29133,"kind":"person","name":"Weiss Lawrence T","position":1,"cik":"0001930293","reported_name":"Weiss Lawrence T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CLO, GC and Corp Sec"}}],"security":"Class A Common Stock","published_at":"2022-05-24T20:16:41.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":690789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest as to 25% on May 23, 2023, with the remainder vesting in three equal annual installments thereafter, subject to Mr. Weiss's continued service through the applicable vesting date."}],"balance_after":690789,"source":{"system":"sec-edgar","filing":"0001104659-22-064245","document":"tm2216668-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804176/000110465922064245/tm2216668-2_4seq1.xml","form_type":"4"}}]}